- Filed
- Apr 24, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $290.33M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $82.25M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $3M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $10.06M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$88.54M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $43.89M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $41.38M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $46.46M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $558.07M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $358.58M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $115.4M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $108.56M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $412.56M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $397.65M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | $0.09 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.05 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | $0.09 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.07 |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $54.28M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $51.09M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 38.84M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $222K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $12.07M |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $17.18M |
| Net Income | Q1 2025 · Mar 31, 2024 | $1.81M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $1.46M |